Recently, we proposed a new methodology for clinical evaluation of insulin sensitivity, S I , and the rate constant of glucose absorption, k abs , from oral glucose tests. This methodology relies on a minimal model of glucose kinetics coupled with a structural description of gastric emptying of glucose and its conversion into the rate of systemic absorption from the gut. The aim of the present study was to test the reproducibility of S I and k abs provided by our model using two data sets from a 300 min frequently sampled oral glucose tolerance test: a full 22-sample data set (OGTT 300/22 ) and a reduced 11-sample data subset (OGTT 300/11 ). Nine subjects, not affected by the metabolic syndrome, participated in the study. Mean (95% confidence interval) values of -2 min -1 , respectively. The concordance of the full and reduced paired samples in providing S I and k abs estimates is supported by intraclass correlation coefficients of 0.93 and 0.97, respectively. Parameter estimates and model based simulations of the rate of glucose appearance into plasma, R a (t), were comparable with data in the literature. In conclusion, our model appears a potentially useful tool to estimate insulin sensitivity and the rate constant of systemic glucose absorption from reduced oral glucose tests.
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Introduction
The measure of an insulin sensitivity index, defined as the ability of insulin to control glucose production and utilisation is of primary importance in the assessment of glucose regulatory system efficiency. Quantitative evaluation of this index is usually accomplished with methods involving an intravenous administration of glucose and/or insulin, such as the glucose clamp or the frequently sampled intravenous glucose tolerance tests (IVGTT) and minimal model technique [1] [2] [3] [4] . Difficulty in the venous administration and high (nonphysiological) levels of glycaemia and insulinemia achieved during these tests are limitations that need to be resolved. Measurement of insulin sensitivity from an oral test, e.g., a meal glucose tolerance test (MGTT) or an oral glucose tolerance test (OGTT), is better suited to normal life condition [5] [6] [7] [8] [9] . Models for interpretation of data from oral tests, however, enhance the problem of describing the rate of appearance into plasma, R a (t), of glucose absorbed from the gastrointestinal tract [5] [6] [7] [8] [9] . Recently, to estimate insulin sensitivity from an OGTT we [9] coupled the classical minimal model of glucose kinetics with a model of the gut, which describes the conversion of ingested glucose into R a (t). This description involves a parameter, k abs , which portrays the physiological meaning of a rate constant of glucose absorption by the systemic circulation from the gut. The aim of the present study was to test the reproducibility of S I and k abs provided by our model using two data sets from a 300 min frequently sampled oral glucose tolerance test: a full 22-sample data set (OGTT 300/22 ) and a reduced 11-sample data subset (OGTT 300/11 ) more suitable for population studies.
Methods

Database
This study included nine subjects (3 men and 6 women with mean age of 49.1 (SD=13.7) yr and body mass index, BMI, of 24.4 (SD=2.9) kg/m 2 , recruited at the Metabolic Disease and Diabetes Unit of the INRCA-IRCCS, Ancona, Italy, and at the Unit of Internal Medicine, "C.G. Mazzoni" General Hospital, Ascoli Piceno, Italy. These subjects were not affected by the metabolic syndrome, MS, defined according to the Adult Treatment Panel III criteria [10] , and had a fasting glycaemia <110 mg/dl.
Each subject underwent an oral glucose tolerance test (OGTT). All they gave informed consent to the procedures approved by the Ethics Committee. Starting time was 8:30 a.m. after overnight fast. A 75 g glucose load was administered and 22 blood samples were taken: one fasting blood sample was taken immediately before glucose administration and twenty-one additional samples were taken at minutes 10, 20, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270 , 285 and 300, after glucose administration [6, 8] .
Blood was promptly centrifuged and glycaemia immediately measured by the glucose oxidase method with an automated glucose analyser. The remaining plasma was stored at -20°C for later insulin dosage. Insulinaemia was determined by commercially available radioimmunoassays (Biodata S.p.A, Guidonia Montecelio, Roma, Italy).
Model formulation
The dynamic relation between plasma insulin and glucose concentration data detected during OGTTs were interpreted by means of a new model, which incorporates the classic minimal model of glucose kinetics [1] coupled with a gut compartment, which is supposed to account for the conversion of ingested glucose dose, D (75 mg), into the rate of post hepatic glucose appearance into plasma R a (t) [11, 12] .
Our model is described by the following equations:
where G(t) is instantaneous glycaemia (mg/dl); I(t) is instantaneous insulinaemia (µU/ml); X(t) is insulin action proportional to insulinaemia deviation from basal in a remote compartment [1] , G b and I b are baseline glycaemia and insulinaemia; VW (dl) is glucose distribution volume; S I is insulin sensitivity [min -1 /(µU·ml -1 )], S G is glucose effectiveness (min -1 ) and p 2 is the rate constant (min -1 ) which governs the speed of rise and decay of insulin action in the remote insulin compartment; G g (t) is glucose mass in the gut (mg); R l (t) accounts for the rate of splanchnic extraction (mg/min) of glucose and R a (t) is the rate of post hepatic appearance (mg/min) of ingested glucose into the systemic circulation. The sum of R a (t) and R l (t) is the rate of glucose delivery by the gut compartment, R d (t). The glucose flow which leaves the stomach and enters the gut compartment is denoted as R s (t) and is described by the following equation:
where the dimensionless parameter β determines the shape of gastric retention decay curve, while τ (min) is the time lasting until 50% of the glucose dose, D, has been delivered. The t i parameter is assumed equal to 1 according to the observation that the administration of the dose D started at minute -1 before the conventional start, t=0 + , of our experimental observation. The rate of glucose delivery by the gut is assumed to be linearly related to the glucose mass in the gut via a delivery constant k d [11, 12] . Only a fraction of glucose delivered by the gut, however, enters the systemic circulation after passage through the liver. Based on dual tracer OGTT, a mean population value of 0.87 has been reported for f [8] . Taking this value into account, the rate of appearance (mg/min) of ingested glucose into plasma can be expressed as:
where the parameter
portrays the physiological meaning of the rate constant of systemic glucose absorption from the gut.
Parameter estimation
Our model is characterised by eight free parameters:
The product of f and k d yields k abs (eq. (6)). Suitable estimates of β and τ were determined by fitting equation (4) to the mean values of the rate of glucose delivery into the duodenum reported by Schirra et al. [13] . For D = 75 g, we found β = 1.15 and τ = 43 min. These values allowed simulation of the R s (t) profile ( Fig. 1 ) to be filled into equation (3) .
From a priori identifiability analysis [14] we found that unique identifiability of parameters S I , p 2 and k d can be accomplished if f, S G and VW are also known. In accordance with estimates reported by Dalla Man [8] from model independent, dual tracer OGTT studies, we assumed reference population values of f = 0.87, S G = 0.028 min -1 and V = 1.34 dl/kg. The product of V times body weight, BW (kg), of individual subjects who underwent the OGTT for the present study yielded VW values (dl) to be filled into equation (1) . Estimation of S I , k d and p 2 was accomplished making use of a weighted non-linear estimation technique implemented by the SAAM II software (SAAM Institute, University of Washington, Seattle, WA) [15] . Weights were optimally chosen, i.e., equal to the inverse of the variance of the glucose measurement errors. The errors associated with total glucose measurements were assumed to be normally distributed random variables with zero mean and a constant percent coefficient of variation (CV%) equal to 2%. Maximum a posteriori Bayesian estimation was employed for p 2 assumed normally distributed with mean 0.012 min -1 and CV%=20% [7, 8] . To assess the goodness of glucose data fit we analyzed the weighted residuals, i.e. the differences between the data and model-predicted values, multiplied by the square root of a weight proportional to the reciprocal of datum SD.
Reproducibility analysis
Intraclass correlation coefficient [16] was used to evaluate the agreement of paired sample sets (OGTT 300/22 and OGTT 300/11 ) in providing S I and k abs estimates, irrespective of CV%, after application of our model. Means and 95% confidence intervals (CI) of estimated indexes were also reported.
Results
On average, fasting glycaemia and insulinaemia were 80.2 (SD=9.0) mg/dl and 5.58 (SD=2.60) µU/ml, respectively. Triglycerides and HDL cholesterol levels were 88.0 (SD=52.5) mg/dl and 57.0 (SD=12.6) mg/dl, respectively.
Data fit was good as judged from the mean weighted residuals which showed no systematic deviation from zero and were within the range [-1,+1] as displayed in Fig. 2 k . After determination of all model parameters we took advantage of our modelling of glucose delivery by the gut to predict (eq. (5)) the time course of the rate of glucose appearance into plasma, R a (t) in individuals. Because G g (t) is expressed in mg and k abs in min -1 , R a (t) was normalised for body weight to obtain a profile in mg·min -1 /kg comparable with data in the literature (see Discussion). The mean profiles provided by the model using the parameters obtained from considering the OGTT 300/22 (continuous line) and the OGTT 300/11 (dashed line) data sets are shown in Fig. 3 . The two curves are practically superimposed and show a bell shape with a steep rise to a peak, occurring about the 60 th min, followed by a slow decrease to zero in about four hours. Comparison between average rate of glucose appearance into plasma predicted by our OGTT minimal model after fitting to the full 22-sample data set (continuous line) and after fitting to the reduced 11-sample data subset (dashed line).
Discussion
The process of setting up a model that allows estimation of insulin sensitivity from oral glucose tests enhances the problem of the description of the rate of appearance of glucose into plasma, R a (t), [5] [6] [7] [8] [9] . To resolve this problem we coupled the minimal model of glucose kinetics, developed for FSIGTT-based studies with a monocompartmental model of the gut that describes the conversion into R a (t) of a dose, D, of glucose ingested during an OGTT. A new mathematical representation (eq. (4)) was introduced to describe the glucose delivery to the gut. This yielded a significant improvement over the function previously assumed by us [9] in fitting the data reported by Schirra et al. [13] . A further improvement was achieved by taking into account that only a fraction, f = 0.87 [8] , of glucose delivered by the gut enters the systemic circulation after passage through the liver, such that the rate of appearance of glucose into plasma is characterized by the rate constant k abs which is 87% of the rate constant, k d , of glucose delivery by the gut. Our model allows estimation of these constants, thus providing information of physiological and clinical interest on glucose delivery to the systemic circulation besides information on the sum effects of insulin to enhance glucose uptake by peripheral tissues and, concomitantly, to suppress liver glucose output.
The ability of our model to provide suitable estimates of these metabolic parameters was tested in subjects who had no history of diabetes mellitus. In selecting the participants to this study we made reference to the ATP III criteria [10] to avoid the confounding effects of MS as a state associated with excess risk of diabetes and cardiovascular disease.
Estimates of insulin sensitivity provided by our model from fitting to the full 22-sample data set (OGTT 300/22 ) can be compared with estimates reported by others after application to normal subjects of other model based methods such as the "integral equation" [5] and the "differential equation" methods [7, 8] . Because the "integral equation" method produces an insulin sensitivity index which has the same units, dl·kg ·min -1 /(µU/ml) reported by Caumo et al [5] for 10 normal subjects. This finding is promising in view of a more thoroughly comparison of our and these previous methods by direct application to our data set.
Easier and less costly applications of oral glucose tests, interpreted with oral minimal models, can be accomplished by reduction of the sampling schedule from 22 to 11. The intraclass correlation coefficients demonstrated a substantial agreement of the two paired methods for estimation of S I and k abs parameters. Further reproducibility analysis involving the CV% associated with individual parameter estimates is desirable to assess the precision of estimated intraclass correlation coefficients and complete the analysis of agreement.
In conceptual terms our new model remains essentially a "differential method" as that first proposed by Dalla Man et al. [7, 8] . A significant difference is that, in our approach, a profile, R s (t), of glucose delivery into the duodenum is assumed (eq. (4)), whereas the "differential method" assumes a R a (t) profile.
An advantage of our approach is that the rate of appearance of glucose into plasma is governed by a physiologically meaningful parameter, k abs . Our mean (CI) estimated values of [17] and Guyton et al. [18] , and used for the AIDA simulation software.
Our estimates of k abs allow prediction (eq. (5)) of the profile of the rate of glucose appearance into plasma, R a (t). On average, the profile obtained after application of our model to the OGTT 300/22 data set is practically superimposed to that obtained from the OGTT 300/11 data set (Fig.3) . Qualitative comparison of this profile with that reported by others from dual tracer OGTT study and with its prediction by the oral minimal model incorporating a piecewise approximation of R a (t) [7, 8] shows a discrepancy in the first thirty minutes. The sharp initial peak which characterizes these reported profiles cannot be reproduced by our oral minimal model. More thoroughly comparison is needed to explain the cause of this discrepancy.
In conclusion, our new model for oral glucose tests appears a potentially useful tool to measure insulin sensitivity and the rate of appearance of glucose into plasma as it relates to glucose delivery by the gut. The present application of our model to normal humans shows that our approach is applicable to a reduced protocol with 11 samples in 5 hours. Further studies are needed to evaluate the sensitivity of model output to alterations of fixed parameters and to asses the applicability of our model in disease states. Integration with information which can be obtained from the alternative "differential equation" approach [7, 8] can contribute to a decisive improvement in the description and interpretation of glucose-insulin system dynamics in health and disease.
